Intertek launches unique pharmaceutical nuclear magnetic resonance spectroscopy (NMR) through its accredited facility.

24 Jul 2014

Manchester, United Kingdom – Intertek, a leading quality solutions provider to industries worldwide, announces the launch of an industry-unique high resolution pharmaceutical Nuclear Magnetic Resonance (NMR) capability. The facility is Good Manufacturing Practice (cGMP) compliant and available through Intertek’s existing centre of excellence for NMR spectroscopy and analytical services, located in Manchester, UK.

The installation of a new 600MHz Bruker Ascend spectrometer with CryoProbeTM functionality provides high sensitivity analysis for a wide range of pharmaceutical applications. The data generated can be used by pharmaceutical clients to support their regulatory submissions and chemistry, manufacturing and controls (CMC) activities including product characterisation, stability, commercial release testing and identification and quantification of low level impurities and process residuals. Clients involved in biopharmaceutical product development will benefit from regulatory NMR data supporting protein characterisation.

Ashleigh Wake, Biotechnology Programme Manager shared “The impressive sensitivity of the new high resolution instrument coupled with GMP compliance and our NMR team’s expertise enables us to provide the highest quality of data for our client’s regulatory requirements.”

Chetan Parmar, Senior Vice President of Intertek Life Sciences, said “This new GMP regulated NMR capability forms a one-of-a-kind NMR contract analysis service. It once again demonstrates Intertek’s continued commitment to provide world class regulatory analytical services supporting our global clients who are developing evermore complex and challenging pharmaceutical products.”

Intertek has a 20 year heritage providing cGMP contract analytical and formulation support, bioanalysis and regulatory affairs services. Intertek’s integrated formulation and analytical teams carry out analytical development, method validation, formulation support, stability testing, extractables / leachables and GMP commercial release testing with specialist expertise for both small and large molecules and also inhalation technologies.

Contacts:
Dr Lorna Kettle, Marketing Manager, Intertek Pharmaceutical Services
Tel.:+44 161 721 1476
Email: lorna.kettle@intertek.com

About Intertek
Intertek is a leading quality solutions provider to industries worldwide. From auditing and inspection, to testing, training, advisory, quality assurance and certification, Intertek adds value for its customers by helping improve the quality and safety of their products, assets and processes. With a network of more than 1,000 laboratories and offices and over 36,000 people in more than 100 countries, Intertek supports companies’ success in the global marketplace, by helping customers to meet end users’ expectations for safety, sustainability, performance, integrity and desirability in virtually any market worldwide. Visit www.intertek.com.